CURRENT AFFAIRS

Detailed explanation-1: -Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh announces India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer.

Detailed explanation-2: -Meanwhile, India’s first indigenously developed vaccine to prevent cervical cancer, CERVAVAC, is all set to be available later this year, costing between ₹200-400 a shot. CERVAVAC will be effective against at least four variants of Human Papilloma Virus (HPV).

Detailed explanation-3: -The Serum Institute of India (SII) launched CERVAVAC, India’s first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine, on Tuesday, January 24, 2023, on the occasion of India’s National Girl Child Day.

Detailed explanation-4: -Gardasil 9 is an HPV vaccine approved by the U.S. Food and Drug Administration and can be used for both girls and boys. This vaccine can prevent most cases of cervical cancer if the vaccine is given before girls or women are exposed to the virus.

Detailed explanation-5: -The cervical cancer vaccine, Quadrivalent Human Papillomavirus vaccine (qHPV), is developed by the Serum Institute of India (SII) and the Department of Biotechnology(DBT).